BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 222761)

  • 1. Interaction of arylazido-beta-alanyl NAD+, a photoaffinity analogue of NAD+, with mitochondrial dihydronicotinamide adenine dinucleotide-ubiquinone reductase.
    Chen S; Guillory RJ
    J Biol Chem; 1979 Aug; 254(15):7220-7. PubMed ID: 222761
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of the ferricyanide reductase activities of the mitochondrial reduced nicotinamide adenine dinucleotide-ubiquinone reductase (complex I) utilizing arylazido-beta-alanyl NAD+ and arylazido-beta-alanyl NADP+.
    Chen S; Guillory RJ
    J Bioenerg Biomembr; 1985 Feb; 17(1):33-49. PubMed ID: 3921531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of arylazido-beta-alanyl NADP+, a photoaffinity analogue of NADP+, with mitochondrial dihydronicotinamide adenine dinucleotide-ubiquinone reductase.
    Chen S; Guillory RJ
    J Biol Chem; 1980 Mar; 255(6):2445-53. PubMed ID: 7358681
    [No Abstract]   [Full Text] [Related]  

  • 4. The reaction mechanism of the mitochondrial pyridine nucleotide transhydrogenase. A study utilizing arylazido-pyridine nucleotide analogues.
    Chen S; Guillory RJ
    J Biol Chem; 1984 May; 259(9):5945-53. PubMed ID: 6715379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the NADH-NAD+ transhydrogenase peptide of the mitochondrial NADH-CoQ reductase (Complex I). A photodependent labeling study utilizing arylazido-beta-alanyl NAD+.
    Chen S; Guillory RJ
    J Biol Chem; 1984 Apr; 259(8):5124-31. PubMed ID: 6425285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arylazido-beta-alanine ADP-ribose, a novel irreversible competitive inhibitor of mitochondrial NADH-ubiquinone reductase.
    Frenkin MV; Kotlyar AB
    Biochim Biophys Acta; 1999 Nov; 1413(3):139-46. PubMed ID: 10556626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of arylazido ubiquinone derivative with mitochondrial ubiquinol-cytochrome c reductase.
    Yu L; Yu CA
    J Biol Chem; 1982 Sep; 257(17):10215-21. PubMed ID: 6286644
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the interaction of arylazido-beta-alanyl NAD+ with the mitochondrial NADH dehydrogenase.
    Chen S; Guillory RJ
    J Biol Chem; 1981 Aug; 256(16):8318-23. PubMed ID: 7263655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-arylazido-beta-alanyl-NAD+, a new NAD+ photoaffinity analogue. Synthesis and labeling of mitochondrial NADH dehydrogenase.
    Deng PS; Hatefi Y; Chen S
    Biochemistry; 1990 Jan; 29(4):1094-8. PubMed ID: 2340277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arylazido-beta-alanine NAD+, and NAD+ photoaffinity analogue. Preparation and properties.
    Chen S; Guillory RJ
    J Biol Chem; 1977 Dec; 252(24):8990-9001. PubMed ID: 200624
    [No Abstract]   [Full Text] [Related]  

  • 11. Photoaffinity labeling of D-(-)-beta-hydroxybutyrate dehydrogenase by (arylazido)-beta-alanyl-substituted nicotinamide adenine dinucleotide.
    Yamaguchi M; Chen S; Hatefi Y
    Biochemistry; 1985 Aug; 24(18):4912-6. PubMed ID: 4074667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current applications of the photoaffinity technique to the study of the structure of complex I.
    Guillory RJ; Jeng SJ; Chen S
    Ann N Y Acad Sci; 1980; 346():244-79. PubMed ID: 6770737
    [No Abstract]   [Full Text] [Related]  

  • 13. Kinetic indication for multiple sites of ubiquinol-1 interaction in ubiquinol-cytochrome c reductase in bovine heart mitochondria.
    Esposti MD; Lenaz G
    Arch Biochem Biophys; 1982 Jul; 216(2):727-35. PubMed ID: 6287942
    [No Abstract]   [Full Text] [Related]  

  • 14. Slow active/inactive transition of the mitochondrial NADH-ubiquinone reductase.
    Kotlyar AB; Vinogradov AD
    Biochim Biophys Acta; 1990 Aug; 1019(2):151-8. PubMed ID: 2119805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between succinate dehydrogenase and ubiquinone-binding protein from succinate-ubiquinone reductase.
    Yu L; Yu CA
    Biochim Biophys Acta; 1980 Nov; 593(1):24-38. PubMed ID: 7426645
    [No Abstract]   [Full Text] [Related]  

  • 16. Mitochondrial reduced nicotinamide-adenine dinucleotide dehydrogenase is transmembranous [proceedings].
    Smith S; Ragan CI
    Biochem Soc Trans; 1978; 6(6):1349-52. PubMed ID: 217785
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective inhibition of mitochondrial NADH-ubiquinone reductase (Complex I) by an alkyl polyoxyethylene ether.
    Suzuki H; Wakai M; Ozawa T
    Biochem Int; 1986 Aug; 13(2):351-7. PubMed ID: 3094534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arylazido nucleotide analogs in a photoaffinity approach to receptor site labeling.
    Guillory RJ; Jeng SJ
    Methods Enzymol; 1977; 46():259-88. PubMed ID: 198629
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of NADH-ubiquinone reductase activity by N,N'-dicyclohexylcarbodiimide and correlation of this inhibition with the occurrence of energy-coupling site 1 in various organisms.
    Yagi T
    Biochemistry; 1987 May; 26(10):2822-8. PubMed ID: 3111526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of lipid phase transitions on the interaction of mitochondrial NADH--ubiquinone oxidoreductase with ubiquinol--cytochrome c oxidoreductase.
    Heron C; Gore MG; Ragan CI
    Biochem J; 1979 Feb; 178(2):415-26. PubMed ID: 220964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.